Skip to content
Pharma Observatory a Scientist.com platform

Medical affairs and KOL teams

Build a KOL shortlist you can explain

Find the people who led trials in a disease, then check publications, NIH funding, hospital affiliations, industry payments and trial activity on one profile.

Individual plan, $249/seat/mo. Card required.

The KOL signal page: counts of investigators, industry dollars, NIH dollars and research dollars, above a score distribution bar chart and a component mix donut chart
The KOL signal page: investigators scored across industry payments, research payments, NIH funding, publications and PI-led trials, from CMS Open Payments and NIH RePORTER. Captured from production data on 2026-10-10.

The problem today

A KOL list usually starts with the names everyone already knows. Checking a candidate means the trial registry, PubMed, NIH grants and payment disclosures, and the same physician is spelled differently in each. When someone asks why a name ranks third, the answer is a vendor score nobody can open.

Why this beats what you do now

  • A ranking you can open. The KOL signal is built from named parts: industry payments, research payments, NIH funding, publications and PI-led trials.
  • One profile per person. Name variants and past affiliations are matched into a single profile, with the merge basis shown.
  • Conflicts in view. Industry payments sit on the same profile as the trial activity.
  • Start this week. The Individual plan is published at $249/seat/mo and starts with a 14-day trial.

What you can answer

Pages marked free open without an account. The rest open in the product, starting with a 14-day trial.

Which publications anchor a disease?

A condition page's Top publications table lists the most relevant papers for a disease, chosen by each paper's own MeSH topical tags with major-topic and recent papers first. Each paper shows its journal and year and links to PubMed.

Free to read Conditions Open the Alzheimer Disease page

Who ranks highest in a disease, and why?

The KOL signal ranks investigators across industry payments, research payments, NIH funding, authored publications and PI-led trials, and can be scoped to one condition. The sources are CMS Open Payments and NIH RePORTER, and the score distribution is charted so a rank can be read in context.

In the product: KOL

What does one investigator's profile show?

A profile carries a clinical biography, the KOL signal, NIH funding, expertise topics, research and industry payments, hospitals and publications. Trial activity is charted by year and phase, with the most-studied conditions listed.

In the product: People

Is this one person or several?

Records that belong to one investigator are merged into a single profile, which says how many records it merged. The merge basis is shown too: the same NPI, or the same name with a shared trial team or affiliation.

In the product: People

Which companies have paid this person?

A profile's Industry payments section reports the total paid, the number of payment records, how many manufacturers paid and the top payer by name, all from CMS Open Payments. Research payments sit in their own section beside it.

In the product: People

Which hospitals do they work with?

The hospital map plots every Medicare-certified US hospital from its CMS address, and an investigator's profile lists the hospitals tied to them. Hospital detail covers US hospitals only.

In the product: Hospitals

Scope

Payment, NPI and hospital data come from US sources, so US profiles are fuller than others. A profile that merges several records says how many it merged and on what basis.

Build one advisory-board shortlist during the trial

Every answer above marked "In the product" opens with the Individual plan.

See all plans

Individual plan, $249/seat/mo, card required.

See the other teams